Ursodeoxycholic acid for primary biliary cirrhosis-Reference-Cited by-同舟云学术

Ursodeoxycholic acid for primary biliary cirrhosis

Published:2012-12-12 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Rudic Jelena S¹²,Poropat Goran³,Krstic Miodrag N⁴,Bjelakovic Goran²⁵,Gluud Christian²

Affiliation:

1. Clinic of Gastroenterology, Clinical Centre of Serbia; Department of Hepatology; Koste Todorovica 2 Belgrade Serbia 11000

2. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100

3. Clinical Hospital Centre Rijeka; Department of Gastroenterology; Kresimirova 42 Rijeka Croatia 51000

4. Clinic of Gastroenterology, Clinical Centre of Serbia, Medical Faculty, University of Belgrade; Belgrade Serbia 11000

5. Medical Faculty, University of Nis; Department of Internal Medicine; Zorana Djindjica 81 Nis Serbia 18000

Publisher

Wiley

Subject

Pharmacology (medical)

Reference230 articles.

1. Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBC;Battezzati;Journal of Hepatology,1993

2. Ursodeoxycholic acid (UDCA) for symptomatic primary biliary cirrhosis (PBC): a double-blind multicenter trial (EASL abstract);Italian Multicenter Project for UDCA Treatment in PBC;Journal of Hepatology,1989

3. Podda M Almasio P Battezzati PM Crosignani A and Italian Multicenter Group for the Study of UDCA in PBC Long-term effect of the administration of ursodeoxycholic acid alone or with colchicine in patients with primary biliary cirrhosis: a double-blind multicenter study Bile Acids and the Hepatobiliary System. From Basic Science to Clinical Practice. Falk Symposium 68 1993 310 5

4. Urodeoxycholic acid (UDCA) for symptomatic primary biliary cirrhosis (PBC): a double-blind multicenter trial [AASLD abstract];Podda;Hepatology,1989

5. Extended follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis (Abstract);Carithers;Gastroenterology,1996

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re-imagining Primary Biliary Cholangitis Care: Patient-Centric, Utilising Biochemistry, Controlling Symptoms;EMJ Hepatology;2024-07-18

2. Immunology of bile acids regulated receptors;Progress in Lipid Research;2024-07

3. Relationship between pruritus and sleep in participants with primary biliary cholangitis in the Phase 2b GLIMMER trial;Journal of Patient-Reported Outcomes;2024-06-12

4. Ursodeoxycholic Acid Modulates the Interaction of miR-21 and Farnesoid X Receptor and NF-κB Signaling;Biomedicines;2024-06-02

5. Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid;European Journal of Internal Medicine;2024-06